Home › Cancro ai polmoni › Illinois › Evanston
Studi clinici su Cancro ai polmoni a Evanston, IL
19 studi su Cancro ai polmoni cercano partecipanti presso sedi a Evanston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
- e altri 1
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
In reclutamentoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
In reclutamentoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
In reclutamentoFase 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi di distanza
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
In reclutamentoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi di distanza
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
In reclutamentoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
A Registry for People With Lung Cancer
In reclutamentoStudio osservazionale
- Endeavor Health, Evanston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
In reclutamentoFase 3
- Illinois Cancer Specialists, Niles · a 6 mi di distanza
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
In reclutamentoFase 2
- Advocate Aurora Health, Park Ridge · a 8 mi di distanza
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · a 5 mi di distanza
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
In reclutamentoVolontari sani benvenuti
- Northwestern University, Evanston
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
In reclutamentoStudio osservazionale
- Northshore University Health System, Evanston
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
In reclutamentoStudio osservazionale
- Advocate Lutheran General Hospital, Park Ridge · a 8 mi di distanza
Studi su Cancro ai polmoni in altre città
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Altri studi a Evanston
- Cancro del polmone non a piccole cellule22 studi
- Cancro al seno13 studi
- Leucemia mieloide acuta11 studi
- Obesità11 studi
- Cancro colorettale10 studi
- Cancro (tutti i tipi)9 studi
- Sovrappeso9 studi
- Colite ulcerosa9 studi
- Cancro alla prostata9 studi
- Malattia di Crohn9 studi
- Insufficienza cardiaca8 studi
- Fibrillazione atriale8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.